Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (3)
Gene Therapy (2)
Nature Communications (2)
Translational Psychiatry (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)
Amendments and Corrections (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Endocrinology
Genetics
Medical research
Neuroscience

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–9 of 9 results

Advanced filters: Author: MA Blankenstein Clear advanced filters

Detection of an oestrogen receptor-like protein in human meningiomas by band shift assay using a synthetic oestrogen responsive element (ERE)

SGA Koehorst
HM Jacobs
MA Blankenstein
Research01 Aug 1993
British Journal of Cancer

Volume: 68, P: 290-294
Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5

CJH van der Kallen
JH Coes
TWA de Bruin
Research01 Aug 1996
British Journal of Cancer

Volume: 74, P: 606-612
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Dedifferentiation state has been associated with therapy resistance in melanoma. Here, the authors uncover a pre-existing NGFR-expressing, targetable subpopulation that is resistant to immunotherapy and other treatments in melanoma cells and preclinical models.

Julia Boshuizen
David W. Vredevoogd
Daniel S. Peeper
ResearchOpen Access07 Aug 2020
Nature Communications

Volume: 11, P: 1-13
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Julia Boshuizen
David W. Vredevoogd
Daniel S. Peeper
Amendments and CorrectionsOpen Access07 Feb 2023
Nature Communications

Volume: 14, P: 1-3
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency

Treatment with setmelanotide, a new-generation MC4R agonist, provides durable weight loss in hyperphagic, leptin receptor–deficient patients, suggesting a pharmacological avenue to treat patients with various MC4R pathway defects.

Karine Clément
Heike Biebermann
Peter Kühnen
Research07 May 2018
Nature Medicine

Volume: 24, P: 551-555
Narcolepsy as a potential risk factor for Schizophrenia

Reyhane Eghtedarian
Anniina M. Tervi
Hanna M. Ollila
ResearchOpen Access17 Feb 2025
Translational Psychiatry

Volume: 15, P: 1-10
Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states

GR Rutteman
W Misdorp
WE van den Brom
Research01 Nov 1988
British Journal of Cancer

Volume: 58, P: 594-599
Retroviral gene therapy in Germany with a view on previous experience and future perspectives

Michael A. Morgan
Melanie Galla
Axel Schambach
ReviewsOpen Access22 Mar 2021
Gene Therapy

Volume: 28, P: 494-512
Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models

K Terada
H Wakimoto
Y Saeki
Research10 Jan 2006
Gene Therapy

Volume: 13, P: 705-714